<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34737243</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2005-1212</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Gut and liver</Title>
          <ISOAbbreviation>Gut Liver</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation.</ArticleTitle>
        <Pagination>
          <StartPage>443</StartPage>
          <EndPage>455</EndPage>
          <MedlinePgn>443-455</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.5009/gnl210162</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND/AIMS" NlmCategory="UNASSIGNED">Circulating tumor cells (CTCs) with cancer stemness have been demonstrated to be a direct cause of tumor recurrence, and only few studies have reported the role of CTCs in liver transplantation (LT) for hepatocellular carcinoma (HCC).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Epithelial cell adhesion molecule+ (EpCAM+), cluster of differentiation 90+ (CD90+) and EpCAM+/CD90+ CTCs were sorted via fluorescence-activated cell sorting, and transcripts level of <i>EpCAM, K19</i> and <i>CD90</i> in the peripheral blood were analyzed via real-time polymerase chain reaction preoperatively and on postoperative days 1 and 7 in 25 patients who underwent living donor liver transplantation (LDLT) for HCC. EpCAM protein was assessed in HCC tissue using immunohistochemical staining. The median follow-up duration was 40 months.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">HCC after LDLT recurred in four out of 25 patients. Detection of EpCAM+ or CD90+ CTCs correlated well with their messenger RNA levels (p&lt;0.05). EpCAM+ CTCs were readily detected in HCC tissue expressing EpCAM protein. The detection of EpCAM+ CTCs or EpCAM+/CD90+ CTCs before surgery and on postoperative day 1 was significantly associated with HCC recurrence after LT (all p&lt;0.05). Pretransplant serum PIVKA-II &gt;100 mAU/mL and postoperative day 1 EpCAM+/CD90+ CTCs were independent risk factors for HCC recurrence (hazard ratio, 14.64; 95% confidence interval, 1.08 to 198.20; p=0.043 and hazard ratio, 26.88; 95% confidence interval, 1.86 to 387.51; p=0.016, respectively).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">EpCAM+/CD90+ CTCs can be used preoperatively and 1 day after LDLT as key biological markers in LT candidate selection and post-LDLT management.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hwang</LastName>
            <ForeName>Hyeo Seong</ForeName>
            <Initials>HS</Initials>
            <Identifier Source="ORCID">0000-0002-0339-1524</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, National Health Insurance Corporation Ilsan Hospital, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yoo</LastName>
            <ForeName>Jeong Eun</ForeName>
            <Initials>JE</Initials>
            <Identifier Source="ORCID">0000-0001-9990-279X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Dai Hoon</ForeName>
            <Initials>DH</Initials>
            <Identifier Source="ORCID">0000-0003-2787-7876</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Yonsei Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Choi</LastName>
            <ForeName>Jin Sub</ForeName>
            <Initials>JS</Initials>
            <Identifier Source="ORCID">0000-0002-6467-6494</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Yonsei Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Jae Geun</ForeName>
            <Initials>JG</Initials>
            <Identifier Source="ORCID">0000-0002-6722-0257</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Joo</LastName>
            <ForeName>Dong Jin</ForeName>
            <Initials>DJ</Initials>
            <Identifier Source="ORCID">0000-0001-8405-1531</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Myoung Soo</ForeName>
            <Initials>MS</Initials>
            <Identifier Source="ORCID">0000-0002-8975-8381</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Soon Il</ForeName>
            <Initials>SI</Initials>
            <Identifier Source="ORCID">0000-0002-0783-7538</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Choi</LastName>
            <ForeName>Gi Hong</ForeName>
            <Initials>GH</Initials>
            <Identifier Source="ORCID">0000-0002-1593-3773</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Yonsei Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Young Nyun</ForeName>
            <Initials>YN</Initials>
            <Identifier Source="ORCID">0000-0003-0357-7967</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Gut Liver</MedlineTA>
        <NlmUniqueID>101316452</NlmUniqueID>
        <ISSNLinking>1976-2283</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C499379">EPCAM protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000071858">Epithelial Cell Adhesion Molecule</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018800">Thy-1 Antigens</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006528" MajorTopicYN="Y">Carcinoma, Hepatocellular</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071858" MajorTopicYN="N">Epithelial Cell Adhesion Molecule</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008113" MajorTopicYN="Y">Liver Neoplasms</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019520" MajorTopicYN="N">Living Donors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014411" MajorTopicYN="N">Neoplastic Stem Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018800" MajorTopicYN="N">Thy-1 Antigens</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Circulating tumor cells</Keyword>
        <Keyword MajorTopicYN="N">Hepatocellular carcinoma</Keyword>
        <Keyword MajorTopicYN="N">Liver transplantation</Keyword>
      </KeywordList>
      <CoiStatement>
<b>CONFLICTS OF INTEREST</b>
. Y.N.P. is an editorial board member of the journal but was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>4</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34737243</ArticleId>
        <ArticleId IdType="pmc">PMC9099395</ArticleId>
        <ArticleId IdType="doi">10.5009/gnl210162</ArticleId>
        <ArticleId IdType="pii">gnl210162</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Mazzaferro V, Regalia E, Doci R, et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699. doi: 10.1056/NEJM199603143341104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199603143341104</ArticleId>
            <ArticleId IdType="pubmed">8594428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazzaferro V, Sposito C, Zhou J, et al.  Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma. Gastroenterology. 2018;154:128–139. doi: 10.1053/j.gastro.2017.09.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2017.09.025</ArticleId>
            <ArticleId IdType="pubmed">28989060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanaka F, Yoneda K, Kondo N, et al.  Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res. 2009;15:6980–6986. doi: 10.1158/1078-0432.CCR-09-1095.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-09-1095</ArticleId>
            <ArticleId IdType="pubmed">19887487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aceto N, Bardia A, Miyamoto DT, et al.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158:1110–1122. doi: 10.1016/j.cell.2014.07.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2014.07.013</ArticleId>
            <ArticleId IdType="pmc">PMC4149753</ArticleId>
            <ArticleId IdType="pubmed">25171411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsai WS, Chen JS, Shao HJ, et al.  Circulating tumor cell count correlates with colorectal neoplasm progression and is a prognostic marker for distant metastasis in non-metastatic patients. Sci Rep. 2016;6:24517.  doi: 10.1038/srep24517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep24517</ArticleId>
            <ArticleId IdType="pmc">PMC4830949</ArticleId>
            <ArticleId IdType="pubmed">27075165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111. doi: 10.1038/35102167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35102167</ArticleId>
            <ArticleId IdType="pubmed">11689955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ji J, Wang XW. Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol. 2012;39:461–472. doi: 10.1053/j.seminoncol.2012.05.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.seminoncol.2012.05.011</ArticleId>
            <ArticleId IdType="pmc">PMC3409471</ArticleId>
            <ArticleId IdType="pubmed">22846863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang W, Yan HX, Chen L, et al.  Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res. 2008;68:4287–4295. doi: 10.1158/0008-5472.CAN-07-6691.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-07-6691</ArticleId>
            <ArticleId IdType="pubmed">18519688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang ZF, Ho DW, Ng MN, et al.  Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell. 2008;13:153–166. doi: 10.1016/j.ccr.2008.01.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2008.01.013</ArticleId>
            <ArticleId IdType="pubmed">18242515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terris B, Cavard C, Perret C. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. J Hepatol. 2010;52:280–281. doi: 10.1016/j.jhep.2009.10.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2009.10.026</ArticleId>
            <ArticleId IdType="pubmed">20006402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi GH, Kim GI, Yoo JE, et al.  Increased expression of circulating cancer stem cell markers during the perioperative period predicts early recurrence after curative resection of hepatocellular carcinoma. Ann Surg Oncol. 2015;22 Suppl 3:S1444–S1452. doi: 10.1245/s10434-015-4480-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1245/s10434-015-4480-9</ArticleId>
            <ArticleId IdType="pubmed">25791790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xue F, Shi S, Zhang Z, et al.  Application of a novel liquid biopsy in patients with hepatocellular carcinoma undergoing liver transplantation. Oncol Lett. 2018;15:5481–5488. doi: 10.3892/ol.2018.8019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ol.2018.8019</ArticleId>
            <ArticleId IdType="pmc">PMC5840532</ArticleId>
            <ArticleId IdType="pubmed">29552189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S, Zheng Y, Liu J, Huo F, Zhou J. Analysis of circulating tumor cells in patients with hepatocellular carcinoma recurrence following liver transplantation. J Investig Med. 2018;66:1–6. doi: 10.1136/jim-2017-000655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jim-2017-000655</ArticleId>
            <ArticleId IdType="pubmed">29632031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Felden J, Villanueva A. Role of molecular biomarkers in liver transplantation for hepatocellular carcinoma. Liver Transpl. 2020;26:823–831. doi: 10.1002/lt.25731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/lt.25731</ArticleId>
            <ArticleId IdType="pubmed">32061009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar A, Bhanja A, Bhattacharyya J, Jaganathan BG. Multiple roles of CD90 in cancer. Tumour Biol. 2016;37:11611–11622. doi: 10.1007/s13277-016-5112-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13277-016-5112-0</ArticleId>
            <ArticleId IdType="pubmed">27337957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamashita T, Honda M, Nakamoto Y, et al.  Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology. 2013;57:1484–1497. doi: 10.1002/hep.26168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26168</ArticleId>
            <ArticleId IdType="pmc">PMC7180389</ArticleId>
            <ArticleId IdType="pubmed">23174907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamashita T, Wang XW. Cancer stem cells in the development of liver cancer. J Clin Invest. 2013;123:1911–1918. doi: 10.1172/JCI66024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI66024</ArticleId>
            <ArticleId IdType="pmc">PMC3635728</ArticleId>
            <ArticleId IdType="pubmed">23635789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamashita T, Ji J, Budhu A, et al.  EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology. 2009;136:1012–1024. doi: 10.1053/j.gastro.2008.12.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2008.12.004</ArticleId>
            <ArticleId IdType="pmc">PMC2828822</ArticleId>
            <ArticleId IdType="pubmed">19150350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tao Y, Wang M, Chen E, Tang H. Liver regeneration: analysis of the main relevant signaling molecules. Mediators Inflamm. 2017;2017:4256352.  doi: 10.1155/2017/4256352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2017/4256352</ArticleId>
            <ArticleId IdType="pmc">PMC5602614</ArticleId>
            <ArticleId IdType="pubmed">28947857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu M, Li S, Menon S, et al.  Expansion and hepatic differentiation of adult blood-derived CD34+ progenitor cells and promotion of liver regeneration after acute injury. Stem Cells Transl Med. 2016;5:723–732. doi: 10.5966/sctm.2015-0268.17d6dd73eb884bc7ad274def007beff7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5966/sctm.2015-0268</ArticleId>
            <ArticleId IdType="pmc">PMC4878335</ArticleId>
            <ArticleId IdType="pubmed">27075766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsui YM, Chan LK, Ng IO. Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential. Br J Cancer. 2020;122:1428–1440. doi: 10.1038/s41416-020-0823-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41416-020-0823-9</ArticleId>
            <ArticleId IdType="pmc">PMC7217836</ArticleId>
            <ArticleId IdType="pubmed">32231294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Theise N, Chua M, Reid LM. The stem cell niche of human livers: symmetry between development and regeneration. Hepatology. 2008;48:1598–1607. doi: 10.1002/hep.22516.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.22516</ArticleId>
            <ArticleId IdType="pubmed">18972441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopresti A, Malergue F, Bertucci F, et al.  Sensitive and easy screening for circulating tumor cells by flow cytometry. JCI Insight. 2019;5:e128180.  doi: 10.1172/jci.insight.128180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/jci.insight.128180</ArticleId>
            <ArticleId IdType="pmc">PMC6675556</ArticleId>
            <ArticleId IdType="pubmed">31194699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuckuck FW, Edwards BS, Sklar LA. High throughput flow cytometry. Cytometry. 2001;44:83–90. doi: 10.1002/1097-0320(20010501)44:1&lt;83::AID-CYTO1085&gt;3.0.CO;2-O.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1097-0320(20010501)44:1&lt;83::AID-CYTO1085&gt;3.0.CO;2-O</ArticleId>
            <ArticleId IdType="pubmed">11309812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goodale D, Phay C, Postenka CO, Keeney M, Allan AL. Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry. Cytometry A. 2009;75:344–355. doi: 10.1002/cyto.a.20657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cyto.a.20657</ArticleId>
            <ArticleId IdType="pubmed">18855920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ho A, Haas R, Champlin RE.  Detection of infrequent cells in blood and bone marrow by flow cytometry. Marcel Dekker Inc.; New York: 2000. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cyto.a.20657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bocsi J, Varga VS, Molnár B, Sipos F, Tulassay Z, Tárnok A. Scanning fluorescent microscopy analysis is applicable for absolute and relative cell frequency determinations. Cytometry A. 2004;61:1–8. doi: 10.1002/cyto.a.20061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cyto.a.20061</ArticleId>
            <ArticleId IdType="pubmed">15351983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grigg SE, Sarri GL, Gow PJ, Yeomans ND. Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther. 2019;49:1260–1273. doi: 10.1111/apt.15253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apt.15253</ArticleId>
            <ArticleId IdType="pubmed">30989721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin LC, Luo ZC, Gao YX, Li Y, Peng Q, Gao Y. Twist expression in circulating hepatocellular carcinoma cells predicts metastasis and prognoses. Biomed Res Int. 2018;2018:3789613.  doi: 10.1155/2018/3789613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2018/3789613</ArticleId>
            <ArticleId IdType="pmc">PMC6038670</ArticleId>
            <ArticleId IdType="pubmed">30046595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan ST, Yang ZF, Ho DW, Ng MN, Yu WC, Wong J. Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study. Ann Surg. 2011;254:569–576. doi: 10.1097/SLA.0b013e3182300a1d.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/SLA.0b013e3182300a1d</ArticleId>
            <ArticleId IdType="pubmed">21892074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun YF, Xu Y, Yang XR, et al.  Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology. 2013;57:1458–1468. doi: 10.1002/hep.26151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26151</ArticleId>
            <ArticleId IdType="pubmed">23175471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qi LN, Xiang BD, Wu FX, et al.  Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma. Cancer Res. 2018;78:4731–4744. doi: 10.1158/0008-5472.CAN-17-2459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-17-2459</ArticleId>
            <ArticleId IdType="pubmed">29915159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ou H, Huang Y, Xiang L, et al.  Circulating tumor cell phenotype indicates poor survival and recurrence after surgery for hepatocellular carcinoma. Dig Dis Sci. 2018;63:2373–2380. doi: 10.1007/s10620-018-5124-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10620-018-5124-2</ArticleId>
            <ArticleId IdType="pubmed">29926241</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
